Jupiter Neurosciences, Inc.
JUNS
$0.64
$0.00761.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 492.70K | 536.40K | 684.00K | 786.10K | 954.80K |
| Gross Profit | -492.70K | -536.40K | -684.00K | -786.10K | -954.80K |
| SG&A Expenses | 2.59M | 1.62M | 2.42M | 2.60M | 2.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.08M | 2.16M | 3.11M | 3.38M | 3.86M |
| Operating Income | -3.08M | -2.16M | -3.11M | -3.38M | -3.86M |
| Income Before Tax | -2.44M | -1.34M | -2.52M | -3.67M | -4.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.44 | -1.34 | -2.52 | -3.67 | -4.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.44M | -1.34M | -2.52M | -3.67M | -4.78M |
| EBIT | -3.08M | -2.16M | -3.11M | -3.38M | -3.86M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.08 | -0.05 | -0.10 | -0.14 | -0.18 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.08 | -0.08 | -0.09 |
| EPS Diluted | -0.08 | -0.05 | -0.10 | -0.15 | -0.19 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.07 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 116.77M | 111.56M | 106.90M | 105.76M | 105.61M |
| Average Diluted Shares Outstanding | 119.83M | 114.62M | 109.95M | 105.76M | 105.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |